Wei Dong Jiang
Gründer bei SHANGHAI HENLIUS BIOTECH, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Wei Dong Jiang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2009 | - |
Gründer | 01.12.2009 | - |
Karriereverlauf von Wei Dong Jiang
Ehemalige bekannte Positionen von Wei Dong Jiang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | - |
Gründer | 01.01.2009 | - |
Ausbildung von Wei Dong Jiang
Zhejiang University | Undergraduate Degree |
University of Giessen | Doctorate Degree |
Statistik
International
China | 3 |
Vereinigte Staaten | 2 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Börse
- Insiders
- Wei Dong Jiang
- Erfahrung